• Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. (2002) Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Research 51:3171.
  • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. (2004) Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Research 61:148.
  • Brandt C, Heile A, Potschka H, Stoehr T, Loscher W. (2006) Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 47:18031809.
  • Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. (2007) Lacosamide: a review of preclinical properties. CNS Drug Reviews 13(1):2142.
  • Cawello W, Kropeit D, Schiltmeyer B, Hammes W, Horstmann R. (2004) Food does not affect the pharmacokinetics of SPM 927 (Abstract). Epilepsia 45(Suppl 7):307.
  • Cramer JA, Ben-Menachem E, French J. (2001) Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Research 47:1725.
  • Errington AC, Coyne L, Stohr T, Selve N, Lees G. (2006) Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50:10161029.
  • Horstmann R, Bonn R, Cawello W, Doty P, Rudd D. (2002) Basic clinical pharmacological investigations of the new antiepileptic drug SPM 927 (Abstract). Epilepsia 43(Suppl 7):188.
  • Hovinga CA. (2003) SPM-927 (Schwarz Pharma). IDrugs 6:479485.
  • Marson AG, Kadir ZA, Chadwick DW. (1996) New antiepileptic drugs: a systematic review of their efficacy and tolerability. British Medical Journal 313:11691174.
  • Sander JW. (2004) The use of antiepileptic drugs—principles and practice. Epilepsia 45(Suppl 6):2834.
  • Stoehr T, Lees G, Errington A, Schrattenholz A, Beyreuther B, Heers C, Freitag J. (2006) Lacosamide has a dual mode of action: selective enhancement of sodium channel slow inactivation and modulation of CRMP-2. 9th International Congress on the Mechanisms and Treatment of Neuropathic Pain.